Latest news in pharma industry

Here are some of the latest news and updates in the pharmaceutical industry:

1. COVID-19 Vaccines:

• Pfizer and BioNTech have announced that their COVID-19 vaccine has been approved for emergency use in the UK, making it the first vaccine to receive regulatory approval in the country.
• Moderna Therapeutics has announced that its COVID-19 vaccine has been approved for emergency use in the US, with the first shipments expected to be delivered in the coming days.
• AstraZeneca has announced that its COVID-19 vaccine has been approved for emergency use in the UK, with the first doses expected to be administered in the coming weeks.

2. Regulatory Updates:

• The US FDA has approved a new indication for Pfizer's breast cancer treatment, Ibrance, to treat patients with HR-positive, HER2-negative advanced breast cancer.
• The European Medicines Agency (EMA) has approved a new indication for Roche's cancer treatment, Alecensa, to treat patients with ALK-positive non-small cell lung cancer.
• The Japanese Ministry of Health, Labour and Welfare has approved a new indication for Takeda's cancer treatment, Ninlaro, to treat patients with multiple myeloma.

3. Mergers and Acquisitions:

• Pfizer has announced that it will acquire Array BioPharma for $11.4 billion, expanding its portfolio of cancer treatments.
• Novartis has announced that it will acquire The Medicines Company for $9.7 billion, gaining access to its cardiovascular and infectious disease treatments.
• GSK has announced that it will acquire TESARO for $5.1 billion, gaining access to its oncology treatments.

4. Research and Development:

• AstraZeneca has announced that it has entered into a collaboration with Merck & Co. to develop a new cancer treatment, combining AstraZeneca's PARP inhibitor, Lynparza, with Merck's checkpoint inhibitor, Keytruda.
• Johnson & Johnson has announced that it has entered into a collaboration with Biogen to develop a new multiple sclerosis treatment, combining J&J's MS treatment, Tysabri, with Biogen's MS treatment, Tecfidera.
• Sanofi has announced that it has entered into a collaboration with Regeneron Pharmaceuticals to develop a new treatment for rare genetic disorders, using Regeneron's gene therapy platform.

5. Pricing and Access:

• The US FDA has announced that it will allow the importation of lower-cost prescription drugs from Canada, in an effort to reduce healthcare costs.
• The European Commission has announced that it will introduce new rules to improve access to medicines, including measures to reduce prices and increase transparency.
• The World Health Organization (WHO) has announced that it will launch a new initiative to improve access to medicines in low- and middle-income countries, including measures to reduce prices and increase production.

These are just a few of the latest news and updates in the pharmaceutical industry. If you would like more information or specific updates on a particular topic, please let me know!